T1	Participants 20 100	maximal gonadotropin dosage used in microdose flare-up cycles in poor responders
T2	Participants 206 294	microdose gonadotropin-releasing hormone analog (GnRH-a) flare cycles in poor responders
T3	Participants 391 400	119 women
T4	Participants 448 459	study group
T5	Participants 587 599	119 patients
T6	Participants 1202 1232	group A, group B, and group C,
T7	Participants 1524 1536	three groups
T8	Participants 1666 1682	microdose cycles
T9	Participants 1797 1813	microdose cycles
T10	Participants 1949 1958	patients.
